Scleroderma
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis The American Journal of Pathology (2010)
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey Rheumatology (2011)
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review Pharmaceuticals (2022)
Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review Advances in Skin & Wound Care (2023)